MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited EBITDA per Share 2011-2026 | VNRX
Annual EBITDA per Share VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.27 | -0.43 | -0.53 | -0.51 | - | -0.392 | -0.55 | -0.537 | -0.526 | -0.551 | -0.432 | -0.386 | 0.00748 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.00748 | -0.551 | -0.426 |
Quarterly EBITDA per Share VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.05 | - | - | - | -0.1 | - | - | - | -0.14 | - | -0.13 | -0.14 | -0.14 | - | -0.13 | -0.1 | -0.12 | - | -0.08 | -0.11 | -0.14 | - | -0.09 | -0.1 | -0.11 | - | -0.12 | -0.14 | -0.16 | - | -0.13 | -0.12 | -0.12 | - | -0.14 | -0.12 | -0.13 | - | -0.16 | -0.11 | -0.14 | - | -0.12 | -0.07 | -0.1 | - | -0.07 | -0.08 | -0.07 | - | -0.08 | -0.08 | -0.08 | - | 0.01 | 0.01 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.01 | -0.16 | -0.105 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Interpace Biosciences
IDXG
|
1.92 | $ 1.71 | 0.73 % | $ 7.5 M |  USA |
 |
Illumina
ILMN
|
-3.01 | $ 124.98 | 0.52 % | $ 19.9 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.1 | -4.11 % | $ 4.82 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
Brainsway Ltd.
BWAY
|
-0.16 | $ 13.78 | 0.88 % | $ 99.4 M | Israel |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 76.15 | -0.37 % | $ 5.14 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 16.37 | 5.54 % | $ 495 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | $ 104.91 | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 8.16 | 2.51 % | $ 1.05 B | USA |
 |
Aspira Women's Health
AWH
|
-0.28 | - | -6.19 % | $ 10.5 M | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 17.59 | 1.56 % | $ 394 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 201.36 | 3.11 % | $ 19.8 B | USA |
 |
Co-Diagnostics
CODX
|
-1.41 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
OPKO Health
OPK
|
-0.08 | $ 1.14 | 1.34 % | $ 791 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Personalis
PSNL
|
-0.97 | $ 7.58 | 4.34 % | $ 449 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 158.0 | 2.92 % | $ 7.83 B | USA |
 |
IQVIA Holdings
IQV
|
19.4 | $ 168.41 | 1.4 % | $ 28.9 B | USA |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
IDEXX Laboratories
IDXX
|
18.7 | $ 582.33 | 0.88 % | $ 46.8 B | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
-70.8 | $ 1.38 | 19.95 % | $ 1.75 M | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 459.17 | 1.47 % | $ 13.2 B | USA |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.63 | 2.31 % | $ 277 M | USA |
 |
Sotera Health Company
SHC
|
0.33 | $ 13.96 | 3.37 % | $ 3.96 B | USA |
 |
Agilent Technologies
A
|
5.49 | $ 112.76 | 1.34 % | $ 34.3 B | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 101.1 | 1.4 % | $ 8.34 B |  Irlanda |
 |
DarioHealth Corp.
DRIO
|
-9.13 | $ 7.5 | -6.13 % | $ 29.9 M | Israel |
 |
Guardant Health
GH
|
-3.17 | $ 85.46 | 0.33 % | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.68 | 2.18 % | $ 433 M | USA |
 |
Soleno Therapeutics
SLNO
|
0.22 | $ 32.26 | -2.89 % | $ 1.64 B | USA |
 |
Psychemedics Corporation
PMD
|
-0.21 | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
1.35 | - | - | $ 10.6 B |  Niderland |
 |
Neuronetics
STIM
|
-0.42 | $ 1.61 | 10.69 % | $ 106 M | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 246.21 | 3.5 % | $ 25.7 B |  Schweiz |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 17.63 | 2.8 % | $ 939 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-20.1 | $ 3.45 | - | $ 1.85 M | USA |
 |
Celcuity
CELC
|
-2.87 | $ 106.93 | 0.84 % | $ 4.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 266.3 | 1.22 % | $ 22.2 B | USA |